Barbara Hibner

713 total citations
11 papers, 519 citations indexed

About

Barbara Hibner is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Barbara Hibner has authored 11 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in Barbara Hibner's work include Cancer Mechanisms and Therapy (3 papers), Cancer Genomics and Diagnostics (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Barbara Hibner is often cited by papers focused on Cancer Mechanisms and Therapy (3 papers), Cancer Genomics and Diagnostics (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Barbara Hibner collaborates with scholars based in United States, Italy and Japan. Barbara Hibner's co-authors include John F. Lyons, S M Wilhelm, Gideon Bollag, William D. Burke, Thomas H. Eickbush, Katherine G. Rendahl, Daniel E. Lopes de Menezes, Millicent Embry, Thomas G. Gesner and Sylvia Ma and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Genetics.

In The Last Decade

Barbara Hibner

11 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Hibner United States	6	391	223	68	64	59	11	519
Candice L. Horn United States	6	457 1.2×	251 1.1×	45 0.7×	55 0.9×	64 1.1×	10	552
Divis Khaira United States	8	378 1.0×	393 1.8×	46 0.7×	101 1.6×	81 1.4×	8	784
Elizabeth Blackwood United States	10	351 0.9×	194 0.9×	51 0.8×	36 0.6×	55 0.9×	26	465
Ryan S. Soderquist United States	13	503 1.3×	194 0.9×	49 0.7×	57 0.9×	77 1.3×	15	652
Kenna Shirasuna Japan	8	370 0.9×	206 0.9×	37 0.5×	59 0.9×	61 1.0×	12	515
Janice M. Mehnert United States	8	303 0.8×	183 0.8×	40 0.6×	36 0.6×	58 1.0×	24	409
Carol F. Franks United States	8	425 1.1×	209 0.9×	32 0.5×	33 0.5×	144 2.4×	10	640
Jorg Michels Canada	8	280 0.7×	151 0.7×	47 0.7×	91 1.4×	71 1.2×	14	451
Steven DellaRocca United States	7	515 1.3×	177 0.8×	53 0.8×	55 0.9×	33 0.6×	12	629
Yvonne Li Canada	9	381 1.0×	161 0.7×	43 0.6×	50 0.8×	92 1.6×	15	525

Countries citing papers authored by Barbara Hibner

Since Specialization

Citations

This map shows the geographic impact of Barbara Hibner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Hibner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Hibner more than expected).

Fields of papers citing papers by Barbara Hibner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Hibner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Hibner. The network helps show where Barbara Hibner may publish in the future.

Co-authorship network of co-authors of Barbara Hibner

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Hibner. A scholar is included among the top collaborators of Barbara Hibner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Hibner. Barbara Hibner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Balakrishna, Deepika, Shweta Pandya, Mark S. Hixon, et al.. (2017). MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody. Molecular Cancer Therapeutics. 16(7). 1269–1278. 11 indexed citations

Hibner, Barbara, et al.. (2013). Takeda's Oncology Discovery Strategy. Japanese Journal of Clinical Oncology. 43(4). 357–361. 1 indexed citations

Tse, Archie, Katherine G. Rendahl, Tahir Sheikh, et al.. (2007). CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo. Clinical Cancer Research. 13(2). 591–602. 117 indexed citations

Taverna, Pietro, Katherine G. Rendahl, Dragana Jekic-McMullen, et al.. (2006). Tezacitabine enhances the DNA-directed effects of fluoropyrimidines in human colon cancer cells and tumor xenografts. Biochemical Pharmacology. 73(1). 44–55. 5 indexed citations

Rendahl, Katherine G., Pietro Taverna, Wendy J. Fantl, et al.. (2004). Optimization of the anti-tumor activity of tezacitabine in combination with fluoropyrimidines in human colon carcinoma cell lines and xenografts. Cancer Research. 64. 688–688. 2 indexed citations

Elting, James J., et al.. (2004). 139 BAY 57-9352: an inhibitor of VEGFR-2 and PDGFR receptor tyrosine kinases that demonstrates anti-angiogenic activity in vitro and in vivo. European Journal of Cancer Supplements. 2(8). 45–45. 2 indexed citations

Lyons, John F., S M Wilhelm, Barbara Hibner, & Gideon Bollag. (2001). Discovery of a novel Raf kinase inhibitor.. Endocrine Related Cancer. 8(3). 219–225. 314 indexed citations

Eberwein, Derek J., et al.. (2001). Dominant negative mutants of mitogen-activated protein kinase pathway. Methods in enzymology on CD-ROM/Methods in enzymology. 332. 353–367. 11 indexed citations

Allen, James, et al.. (1996). The Role of Permission: Two Decades Later. Transactional Analysis Journal. 26(3). 196–205. 7 indexed citations

10.

Sahasrabudhe, Deepak M., et al.. (1993). Shared T cell-defined antigens on independently derived tumors.. The Journal of Immunology. 151(11). 6302–6310. 4 indexed citations

11.

Hibner, Barbara, William D. Burke, & Thomas H. Eickbush. (1991). Sequence identity in an early chorion multigene family is the result of localized gene conversion.. Genetics. 128(3). 595–606. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact